NeoNeuro invents and patents the aptamarker platform, an agnostic approach for the identification of aptamers that bind to diagnostically meaningful targets
neoaptamers
This website uses cookies to improve your experience. We'll assume you accept this policy as long as you are using this websiteAcceptView Policy
French 
English 
Spanish